RxDoctor Payments Data

George Pankey

Infectious Disease · New Orleans, LANPI 1609822956

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,550 of the $2,564 with a category attached, or 99.4%. Abbott accounts for 99.4% of it on its own, with 1 other manufacturer making up the rest.

$2,564in general payments, 2019–2025

Across 2 payments — averaging $1282.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Paratek Pharmaceuticals, Inc.$14
$848,870in research payments, 2019–2025

Across 2 payments — averaging $424,435 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • T2 Biosystems, Inc.$849K

What the payments were for

  • Consulting fees$2,55099%
  • Food & beverage$141%

General payments by program year

21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott1$2,550
Paratek Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,564 in reported general payments places this provider in the 70th percentile of 105 infectious disease providers in Louisiana.

See all infectious disease providers in Louisiana →

Other infectious disease in New Orleans

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →